14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $18.05 $25.44 Wednesday, 1st May 2024 PHVS stock ended at $24.57. This is 0.0813% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.64% from a day low at $23.16 to a day high of $25.16.
90 days $18.05 $33.00
52 weeks $7.93 $33.00

Historical Pharvaris B.V. prices

Date Open High Low Close Volume
Apr 01, 2021 $27.84 $29.50 $26.40 $27.95 384 714
Mar 31, 2021 $27.74 $29.70 $26.61 $27.98 31 886
Mar 30, 2021 $25.00 $26.00 $25.00 $25.99 13 286
Mar 29, 2021 $26.00 $27.10 $25.02 $25.69 166 363
Mar 26, 2021 $26.47 $27.50 $26.12 $26.23 81 173
Mar 25, 2021 $29.95 $30.26 $24.41 $26.72 119 559
Mar 24, 2021 $32.01 $32.23 $29.89 $30.32 83 799
Mar 23, 2021 $33.21 $34.00 $30.56 $32.39 145 170
Mar 22, 2021 $33.03 $35.49 $29.93 $33.04 89 485
Mar 19, 2021 $35.25 $35.25 $33.25 $33.25 95 125
Mar 18, 2021 $34.03 $36.31 $34.03 $35.75 18 319
Mar 17, 2021 $34.19 $36.24 $33.45 $34.40 16 008
Mar 16, 2021 $33.65 $35.89 $31.82 $34.60 47 810
Mar 15, 2021 $28.92 $36.82 $28.92 $34.39 35 120
Mar 12, 2021 $28.34 $31.44 $28.34 $30.90 24 949
Mar 11, 2021 $30.99 $31.85 $29.06 $29.99 32 666
Mar 10, 2021 $27.65 $32.20 $25.53 $29.39 44 679
Mar 09, 2021 $27.41 $29.00 $24.37 $27.39 180 834
Mar 08, 2021 $29.07 $31.50 $26.06 $27.06 77 323
Mar 05, 2021 $34.06 $34.62 $28.14 $28.75 139 847
Mar 04, 2021 $38.25 $39.20 $32.21 $33.61 202 912
Mar 03, 2021 $38.70 $39.85 $36.30 $38.50 115 950
Mar 02, 2021 $38.48 $40.83 $37.08 $38.75 74 400
Mar 01, 2021 $38.44 $41.60 $38.44 $39.23 108 853
Feb 26, 2021 $38.94 $40.42 $35.69 $37.99 116 072
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT